Marshall Wace’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$102M Buy
2,120,692
+1,723,954
+435% +$75.5M 0.11% 165
2025
Q4
$15.3M Sell
396,738
-1,086,938
-73% -$41.4M 0.01% 727
2025
Q3
$52.3M Buy
+1,483,676
New +$53.7M 0.06% 307
2024
Q3
Sell
-945,840
Closed -$24.9M 2923
2024
Q2
$24.9M Sell
945,840
-510,060
-35% -$14.1M 0.04% 433
2024
Q1
$44.2M Buy
1,455,900
+15,857
+1% +$467K 0.07% 282
2023
Q4
$40.5M Buy
1,440,043
+1,275,233
+774% +$35M 0.08% 287
2023
Q3
$4.47M Sell
164,810
-1,641,811
-91% -$48.8M 0.01% 915
2023
Q2
$55.5M Buy
1,806,621
+1,134,091
+169% +$38.4M 0.12% 196
2023
Q1
$24.2M Buy
+672,530
New +$24.9M 0.06% 401
2022
Q4
Sell
-432,250
Closed -$17.4M 3425
2022
Q3
$17.4M Buy
+432,250
New +$18.5M 0.04% 527
2022
Q2
Sell
-74,655
Closed -$2.91M 3855
2022
Q1
$2.91M Sell
74,655
-116,191
-61% -$4.56M 0.01% 1811
2021
Q4
$7.61M Sell
190,846
-1,011,134
-84% -$39.3M 0.02% 1065
2021
Q3
$43.4M Buy
+1,201,980
New +$46.7M 0.22% 99
2020
Q4
Sell
-29,255
Closed -$1.23M 2142
2020
Q3
$1.23M Buy
+29,255
New +$1.26M 0.01% 945

Other funds holding RPRX